Oxycodone on Packaging Line Leads to Recall of Betaxolol
Betaxolol may cause a slowing in the heart rate in some patients; an opioid could increase the effect.
KVK-Tech is voluntarily recalling one lot of Betaxolol Tablets, USP 10 mg, which is a beta blocker used to treat patients with hypertension and also used to treat glaucoma. The company is making the recall as a precautionary measure after one tablet Oxycodone HCl tablet 5 mg was found on the packaging line of Betaxolol.
KVK has not received any reports of foreign tablet in any bottle of Betaxolol.
Betaxolol has a warning on its label about the possibility of a slowing in the heart rate in elderly patients. This effect could be increased by inadvertent opioid administration. Additionally, some patients prescribed low-dose betaxolol might be have compromised heart and lung function that is also likely to be exacerbated by an opioid, the company said.
The affected Betaxolol has a lot number of 17853A and has an expiration date of June 2027. The batch was distributed nationwide to wholesalers and retailers.
FDA Issues Complete Response for High-Dose Opioid Rescue Med
July 16th 2024OX124 is a nasal spray provides rapid absorption of naloxone for patients experiencing an opioid overdose. The FDA would like to see additional technical data, as well as data on whether patients can correctly use the device.
Read More
